BACKGROUND: Glutathione peroxidase-3 (GPx-3) is a selenocysteine-containing plasma protein that scavenges reactive oxygen species in the extracellular compartment. A deficiency of this enzyme has been associated with platelet-dependent thrombosis, and a promoter haplotype with reduced function has been associated with stroke risk. METHODS AND RESULTS: We recently developed a genetic mouse model to assess platelet function and thrombosis in the setting of GPx-3 deficiency. The GPx-3((-/-)) mice showed an attenuated bleeding time and an enhanced aggregation response to the agonist ADP compared with wild-type mice. GPx-3((-/-)) mice displayed increased plasma levels of soluble P-selectin and decreased plasma cyclic cGMP compared with wild-type mice. ADP infusion-induced platelet aggregation in the pulmonary vasculature produced a more robust platelet activation response in the GPx-3((-/-)) than wild-type mice; histological sections from the pulmonary vasculature of GPx-3((-/-)) compared with wild-type mice showed increased platelet-rich thrombi and a higher percentage of occluded vessels. Cremaster muscle preparations revealed endothelial dysfunction in the GPx-3((-/-)) compared with wild-type mice. With a no-flow ischemia-reperfusion stroke model, GPx-3((-/-)) mice had significantly larger cerebral infarctions compared with wild-type mice and platelet-dependent strokes. To assess the neuroprotective role of antioxidants in this model, we found that manganese(III) meso-tetrakis(4-benzoic acid)porphyrin treatment reduced stroke size in GPx-3((-/-)) mice compared with vehicle-treated controls. CONCLUSIONS: These findings demonstrate that GPx-3 deficiency results in a prothrombotic state and vascular dysfunction that promotes platelet-dependent arterial thrombosis. These data illustrate the importance of this plasma antioxidant enzyme in regulating platelet activity, endothelial function, platelet-dependent thrombosis, and vascular thrombotic propensity.
BACKGROUND:Glutathione peroxidase-3 (GPx-3) is a selenocysteine-containing plasma protein that scavenges reactive oxygen species in the extracellular compartment. A deficiency of this enzyme has been associated with platelet-dependent thrombosis, and a promoter haplotype with reduced function has been associated with stroke risk. METHODS AND RESULTS: We recently developed a genetic mouse model to assess platelet function and thrombosis in the setting of GPx-3 deficiency. The GPx-3((-/-)) mice showed an attenuated bleeding time and an enhanced aggregation response to the agonist ADP compared with wild-type mice. GPx-3((-/-)) mice displayed increased plasma levels of soluble P-selectin and decreased plasma cyclic cGMP compared with wild-type mice. ADP infusion-induced platelet aggregation in the pulmonary vasculature produced a more robust platelet activation response in the GPx-3((-/-)) than wild-type mice; histological sections from the pulmonary vasculature of GPx-3((-/-)) compared with wild-type mice showed increased platelet-rich thrombi and a higher percentage of occluded vessels. Cremaster muscle preparations revealed endothelial dysfunction in the GPx-3((-/-)) compared with wild-type mice. With a no-flow ischemia-reperfusion stroke model, GPx-3((-/-)) mice had significantly larger cerebral infarctions compared with wild-type mice and platelet-dependent strokes. To assess the neuroprotective role of antioxidants in this model, we found that manganese(III) meso-tetrakis(4-benzoic acid)porphyrin treatment reduced stroke size in GPx-3((-/-)) mice compared with vehicle-treated controls. CONCLUSIONS: These findings demonstrate that GPx-3 deficiency results in a prothrombotic state and vascular dysfunction that promotes platelet-dependent arterial thrombosis. These data illustrate the importance of this plasma antioxidant enzyme in regulating platelet activity, endothelial function, platelet-dependent thrombosis, and vascular thrombotic propensity.
Authors: T Seno; N Inoue; D Gao; M Okuda; Y Sumi; K Matsui; S Yamada; K I Hirata; S Kawashima; R Tawa; S Imajoh-Ohmi; H Sakurai; M Yokoyama Journal: Thromb Res Date: 2001-09-01 Impact factor: 3.944
Authors: Florian Krötz; Hae Young Sohn; Torsten Gloe; Stefan Zahler; Tobias Riexinger; Thomas M Schiele; Bernhard F Becker; Karl Theisen; Volker Klauss; Ulrich Pohl Journal: Blood Date: 2002-08-01 Impact factor: 22.113
Authors: H Rubbo; R Radi; M Trujillo; R Telleri; B Kalyanaraman; S Barnes; M Kirk; B A Freeman Journal: J Biol Chem Date: 1994-10-21 Impact factor: 5.157
Authors: Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling Journal: Circ Res Date: 2018-03-16 Impact factor: 17.367
Authors: Chad S Weldy; Ian P Luttrell; Collin C White; Vicki Morgan-Stevenson; David P Cox; Christopher M Carosino; Timothy V Larson; James A Stewart; Joel D Kaufman; Francis Kim; Kanchan Chitaley; Terrance J Kavanagh Journal: Inhal Toxicol Date: 2013-07-01 Impact factor: 2.724
Authors: Andrew G Cox; Allison Tsomides; Andrew J Kim; Diane Saunders; Katie L Hwang; Kimberley J Evason; Jerry Heidel; Kristin K Brown; Min Yuan; Evan C Lien; Byung Cheon Lee; Sahar Nissim; Bryan Dickinson; Sagar Chhangawala; Christopher J Chang; John M Asara; Yariv Houvras; Vadim N Gladyshev; Wolfram Goessling Journal: Proc Natl Acad Sci U S A Date: 2016-09-01 Impact factor: 11.205
Authors: Sol Schulman; Pavan Bendapudi; Anish Sharda; Vivien Chen; Lola Bellido-Martin; Reema Jasuja; Barbara C Furie; Robert Flaumenhaft; Bruce Furie Journal: Antioxid Redox Signal Date: 2015-11-18 Impact factor: 8.401
Authors: Chad S Weldy; Ian P Luttrell; Collin C White; Vicki Morgan-Stevenson; Theo K Bammler; Richard P Beyer; Zahra Afsharinejad; Francis Kim; Kanchan Chitaley; Terrance J Kavanagh Journal: Free Radic Biol Med Date: 2012-07-21 Impact factor: 7.376
Authors: A Brill; T A Fuchs; A S Savchenko; G M Thomas; K Martinod; S F De Meyer; A A Bhandari; Denisa D Wagner Journal: J Thromb Haemost Date: 2012-01 Impact factor: 5.824
Authors: Sanjana Dayal; Katina M Wilson; David G Motto; Francis J Miller; Anil K Chauhan; Steven R Lentz Journal: Circulation Date: 2013-02-20 Impact factor: 29.690